NCT00183274View on ClinicalTrials.gov

Effectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XR

PHASE4CompletedINTERVENTIONAL

Enrollment

268

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Anxiety Disorders

Interventions

DRUG

Venlafaxine XR

Six month intervention of Venlafaxine XR treatment with flexible range of 75 to 225 mg/d

DRUG

Placebo

six month intervention with placebo drug

Trial Locations (1)

19104-3309

University of Pennsylvania, 3535 Market Street, Suite 670, Philadelphia

All Listed Sponsors

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Pennsylvania

OTHER

NCT00183274 - Effectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XR | Biotech Hunter | Biotech Hunter